On September 27, 2018 Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, reported that the Company will present at the following upcoming investor conferences (Press release, Verastem, SEP 27, 2018, View Source;p=RssLanding&cat=news&id=2369325 [SID1234529622]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cantor Fitzgerald Global Healthcare Conference on Tuesday, October 2, 2018 at 4:00pm EDT in New York City, NY, USA
The Leerink Partners Roundtable Series: Rare Disease & Oncology on Wednesday, October 3, 2018 at 8:00am EDT in New York City, NY, USA
A live webcast of each presentation will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 90 days.